Characteristics and treatment patterns of older ms patients treated with peginterferon beta-1a or intramuscular interferon beta-1a in the real world

被引：0
|
作者：
Vignos, M. [1 ]
Altincatal, A. [1 ]
Mendoza, J. [1 ]
Avila, R. [1 ]
Makin, C. [1 ]
机构：
[1] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0844
引用
收藏
页码：520 / 520
页数：1
相关论文
共 50 条
  • [41] Widespread maculopapular rash due to intramuscular interferon beta-1a during the treatment of multiple sclerosis
    Serarslan, G.
    Okuyucu, Ee
    Melek, Im
    Hakverdi, S.
    Duman, T.
    MULTIPLE SCLEROSIS, 2008, 14 (02): : 259 - 261
  • [42] Cardiac arrhythmia induced by interferon beta-1a
    Kastalli, Sarrah
    El Aidli, Sihem
    Mourali, Sami
    Zaiem, Ahmed
    Daghfous, Riadh
    Lakhal, Mohamed
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (02) : 207 - 209
  • [43] Randomized, comparative study of interferon beta-1a treatment regimens in MS: the EVIDENCE trial
    Byrne, E
    NEUROLOGY, 2003, 60 (11) : 1872 - 1872
  • [44] New pen device for interferon beta-1a
    不详
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2011, 15 (04) : 32 - 32
  • [45] Behavioral conditioning with interferon beta-1a in humans
    Goebel, MU
    Hübell, D
    Kou, W
    Janssen, OE
    Katsarava, Z
    Limmroth, V
    Schedlowski, M
    PHYSIOLOGY & BEHAVIOR, 2005, 84 (05) : 807 - 814
  • [46] Benefit of higher dosage of interferon beta-1a
    不详
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2015, 19 (06) : 35 - 35
  • [47] PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update
    Reuss, Reinhard
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 131 - 138
  • [48] Effectiveness and health care utilization of patients with MS treated with subcutaneous interferon beta-1a (sc IFN beta-1a) according to age: A cohort study using a US claims database
    Sabido, M.
    Allignol, A.
    Marhardt, K.
    Vermersch, P.
    Boutmy, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1132 - 1132
  • [49] Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis
    Cristina Guijarro
    Julián Benito-León
    Félix Bermejo-Pareja
    Neurological Sciences, 2011, 32 : 309 - 311
  • [50] Utilization and safety of intramuscular interferon beta-1a in the post-marketing setting
    Hyde, R.
    Curnow, K.
    Foulds, P.
    Richman, S.
    Friend, S.
    Glick, G.
    Onigman, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 493 - 493
12345